Dr. Agarwals Health Care Share Price

Healthcare Facilities company Dr. Agarwals Health Care announced Q4FY26 & FY26 results Consolidated Financial Highlights: Total Income: For Q4FY26, total income stood at Rs 577 crore, representing a YoY growth of 21.2% from Rs 476 crore in Q4FY25 and a QoQ growth of 6.77% from Rs 540.40 crore in Q3FY26. For the full year FY26, total income reached Rs 2,125 crore, up 20.9% YoY from Rs 1,757 crore in FY25. Revenue from Operations: In Q4FY26, revenue was Rs 564.11 crore, reflecting a YoY increase of 22.57% compared to Rs 460.22 crore in Q4FY25 and a QoQ increase of 6.46% from Rs 529.86 crore in Q3FY26. Annual revenue for FY26 grew by 21.57% YoY to Rs 2,080.08 crore from Rs 1,711 crore in FY25. EBITDA and Margins: EBITDA for Q4FY26 was Rs 174 crore, showing a YoY growth of 18.9% from Rs 146 crore and a QoQ growth of 12.55% from Rs 154.64 crore. EBITDA margins for the quarter stood at 30.2%. For FY26, EBITDA reached Rs 614 crore, growing by 22.2% YoY from Rs 502 crore in FY25, with an annual margin of 28.9%. Profit After Tax (PAT): For Q4FY26, PAT was Rs 50 crore, up 17.4% YoY from Rs 43 crore and up 14.51% QoQ from Rs 43.63 crore. For the full year FY26, PAT soared by 52.4% YoY to Rs 168 crore compared to Rs 110 crore in FY25. Earnings Per Share (EPS): Annual Basic EPS for FY26 stood at Rs 4.21, compared to Rs 2.80 in FY25. Standalone Financial Highlights: Total Income: Q4FY26 total income was Rs 354.07 crore, compared to Rs 307.95 crore in Q4FY25 and Rs 341.95 crore in Q3FY26. Full year FY26 total income stood at Rs 1,326.55 crore, up from Rs 1,097.70 crore in FY25. Revenue from Operations: Revenue for Q4FY26 was Rs 347.86 crore, a growth of 23.78% YoY from Rs 281.02 crore and 3.89% QoQ from Rs 334.84 crore. Annual revenue for FY26 reached Rs 1,293.39 crore, up 23.90% YoY from Rs 1,043.89 crore in FY25. Profit After Tax (PAT): Q4FY26 PAT was Rs 10.60 crore, a decrease compared to Rs 26.51 crore in Q4FY25 and Rs 14.06 crore in Q3FY26. Full year FY26 PAT stood at Rs 39.45 crore, representing a growth of 79.89% YoY from Rs 21.93 crore in FY25. Business Highlights: Network Expansion: As of March 31, 2026, the company operates a network of 288 facilities across 10 countries. During FY26, the company commissioned 57 new facilities (one every single week), entering 26 new cities. The Q4FY26 alone saw the addition of 19 new centers. Segment Performance: The Group operates in a single reportable segment, namely "Eye Care related sales and services." Surgical Volume: The company performed 84,962 surgeries in Q4FY26 (+23.6% YoY) and a total of 323,245 surgeries in FY26 (+14.5% YoY). Revenue Contribution: For the full year FY26, sale of services contributed 78.4% of revenue, while sale of products contributed 21.6%. Mature facilities revenue grew by 35.3% YoY to reach Rs 1,632 crore. IPO Proceeds Reallocation: The Board approved the reallocation of the unspent portion of "Issue Related Expenses" amounting to Rs 14.884 crore to "General Corporate Purposes and Unidentified Inorganic Acquisitions." Total unutilized IPO proceeds as of March 31, 2026, stood at Rs 23.141 crore. Strategic Moves: The company acquired the remaining stake in Aditya Jyot Eye Hospital Private Limited, making it a wholly-owned subsidiary. A proposed scheme of amalgamation with its subsidiary, Dr. Agarwal's Eye Hospital Limited (AEHL), was approved by the Board and is subject to further regulatory approvals. The company successfully entered the Delhi NCR region through organic growth, establishing six operational facilities within twelve months. Adil Agarwal, CEO, Dr. Agarwal’s Health Care, said: "FY2026 has been a landmark year for Dr. Agarwal's Health Care on every dimension. For the first time in our history, we crossed Rs 2,000 crore in revenues from operations — a milestone that reflects the trust of over 30 lakh patients and the dedication of every doctor and team member across our network. Revenue from operations grew 21.6%, EBITDA expanded 22.2% to Rs 614 crore with margins at 28.9%, and profit after tax grew 52.4% to Rs 168 crore. On the network front, FY2026 saw us commission 57 new facilities — one every single week — entering 26 new cities and taking our total network to 288 facilities across 10 countries. Of the 57 additions, 30 were surgical centres, further strengthening our clinical capacity. Our entry into Delhi NCR, pursued entirely through organic growth, has also been a particular highlight with six facilities now operational across the region in under twelve months. A year ago, we set out with clear targets. Today, we close the year having delivered on each one of them. We enter FY2027 with strong momentum, conviction, and a clear plan to expand faster, deliver ever higher standards of clinical excellence, and serve more patients than ever before.” Result PDF

• Trendlyne
• 6 days 17 hours ago

Healthcare Facilities company Dr. Agarwals Health Care announced Q3FY26 results As of December 31, 2025, our network stands at 272 facilities, with 14 new centers added during the quarter comprising of 9 secondary and 5 primary facilities. Performed 81,002 surgeries in Q3FY26, growth of 11.2% YoY. Total Income of Rs 540 crore; growth of 21.9% YoY. Revenue from Operations of Rs 530 crore; growth of 23.0% YoY. Revenue from Operations - India of Rs 480 crore, growth of 23.1% YoY. Revenue from Mature Facilities of Rs 405 crore, growth of 37.8% YoY. Sale of Services contributed 78.8% and Sale of Products contributed 21.2% to revenue from operations. EBITDA of Rs 155 crore, growth of 21.3% YoY with EBITDA margins of 28.6%. Profit after Tax of Rs 44 crore, growth of 54.5% YoY with profit after tax margins of 8.1%. Adil Agarwal, CEO, Dr. Agarwal’s Health Care, said: “The Company delivered a strong performance in Q3FY26, marked by robust growth across revenues and profitability, reflecting sustained execution momentum. For the Q3FY26, Revenue from Operations grew by 23.0% YoY to Rs 530 crore, driven by healthy patient volumes, strong traction across mature centres, and improving contribution from newer facilities. EBITDA increased by 21.3% YoY to Rs 155 crore, underscoring the resilience of the operating model and disciplined cost management. On the operational front, our network expanded to 272 eye care facilities as of December 31, 2025 with 38 additions during the nine months period ending December, 2025. We served over 22 lakh patients and performed over 238,000 surgeries, supported by our team of 900+ doctors. The Company remains focused on accelerating organic growth through aggressive greenfield expansion, deepening its presence in existing markets while selectively entering newer geographies. Leveraging its brand strength and scalable platform, Dr. Agarwal’s Healthcare continues to drive sustainable growth while maintaining high standards of patient safety and clinical quality. The Company remains confident of meeting its annual guidance, supported by resilient demand and strong momentum in its expansion plans.” Result PDF

• Trendlyne
• 3 months 3 weeks ago

Healthcare Facilities company Dr. Agarwals Health Care announced Q2FY26 results As of September 30, 2025, our network stands at 258 facilities, with 11 new centers added during the quarter comprising of 6 secondary and 5 primary facilities - Performed 78,399 surgeries in Q2FY26, growth of 13.3% YoY. Total Income of Rs 507 crore; growth of 18.2% YoY. Revenue from Operations of Rs 499 crore; growth of 19.7% YoY. Revenue from Operations. India of Rs 445 crore, growth of 19.8% YoY. Revenue from Mature Facilities of Rs 371 crore, growth of 12.7% YoY. Sale of Services contributed 78.1% and Sale of Products contributed 21.7% to revenue from operations. EBITDA of Rs 144 crore, growth of 21.2% YoY with EBITDA margins of 28.4%. Profit after Tax of Rs 36 crore, growth of 71.0% YoY with profit after tax margins of 7.2%. Adil Agarwal, CEO, Dr. Agarwal’s Health Care, said: “The company delivered a steady performance in H1FY26 crossing the Rs 1,000 crore Total Income milestone for the first time — marking a significant achievement in its growth journey. EBITDA for H1FY26 grew by 24.9% YoY to Rs 285 crore, and profit after tax rose by 88.4% to Rs 75 crore, reflecting improved operating efficiencies, disciplined cost management, and stronger margins. While topline growth moderated compared to the previous quarter due to festivities and heavy rainfall, margins strengthened, demonstrating continued focus on profitability and operational excellence. On the operational front, our network expanded to 258 eye care facilities as of September 30, 2025 with 24 additions during the first half. We served over 14 lakh patients and performed over 157,000 surgeries, supported by our team of 880+ doctors. Our recent entry into the Delhi market has seen encouraging traction, and we plan to further accelerate our expansion across North India. We remain confident of meeting our annual guidance, driven by resilient demand and the momentum in our expansion plans. As the second half of the year typically delivers stronger performance, we expect the momentum to further build through FY26.” Result PDF

• Trendlyne
• 6 months 3 weeks ago